How a Bacterial Pathogen Crosses the Blood-Brain Barrier
Author Information
Author(s): Chang Yung-Chi, Wang Zhipeng, Flax Lindsay A., Xu Ding, Esko Jeffrey D., Nizet Victor, Baron Miriam J.
Primary Institution: University of California, San Diego
Hypothesis
Can glycosaminoglycan interactions influence the ability of group B Streptococcus to breach the blood-brain barrier and cause CNS infection?
Conclusion
The study identifies that glycosaminoglycan interactions play a significant role in the ability of group B Streptococcus to penetrate the blood-brain barrier and cause meningitis.
Supporting Evidence
- Glycosaminoglycan interactions were shown to facilitate the entry of group B Streptococcus into the central nervous system.
- Mutations that impair glycosaminoglycan binding reduced bacterial dissemination in Drosophila models.
- Reduced glycosaminoglycan expression in mice led to decreased bacterial penetration of the blood-brain barrier.
Takeaway
Bacteria can use special sugar molecules on our cells to get into our brains, which can make us sick. This study helps us understand how that happens.
Methodology
The study used Drosophila and mouse models to investigate the role of glycosaminoglycan interactions in bacterial penetration of the blood-brain barrier.
Limitations
The study primarily focuses on specific models and may not fully represent human conditions.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website